The BRAF V600E mutation, resulting from the BRAFT1799A transversion, is the most
common genetic mutation in papillary thyroid carcinoma (PTC), with a mean frequency close …

Papillary thyroid carcinoma (PTC) is the most common type of thyroid malignancy and
includes several histological variants. Patients suffering from PTC usually have a good …

Context: The relevance of the BRAF V600E mutation in papillary thyroid carcinoma (PTC) as
a negative prognostic factor is a subject of intense debate. This mutation has been …

BACKGROUND. Numerous studies have investigated the clinical significance of BRAF
mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on …

Papillary thyroid cancer (PTC) is the most common endocrine malignancy, accounting for 85–
90% of all thyroid cancers. Genetic alternations involving the mitogen-activated protein …

Background: The BRAF mutation has been shown to be associated with aggressive
clinicopathologic characteristics of papillary thyroid cancer (PTC). However, several studies …

Objective Papillary thyroid carcinoma (PTC) accounts for 95% of all thyroid carcinomas. PTC
is an epithelial tumor characterized by the proliferation of follicular cells with distinctive …

Papillary thyroid carcinoma (PTC) is the most common histotype among the thyroid cancer
types. Although PTC is a curable malignancy, many patients relapse after treatment. Thus …

The aim of the present study was to investigate the prevalence of the BRAF V600E mutation
in papillary thyroid carcinoma (PTC) and to determine the correlation between this mutation …

Background BRAF V600E mutation is common in papillary thyroid carcinoma (PTC) but its
prognostic value and influence on tumor recurrence is controversial. We investigated if …